Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Williams

Showing results (141-150 of 148) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 148 results.
BMJ Neurology Open|September 12, 2024
Brain reserve and physical disability in secondary progressive multiple sclerosisNevin John, Yingtong Li, Floriana De Angelis, et al.
Nature Microbiology|January 28, 2021
Author Correction: Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into ScotlandAna da Silva Filipe, James G Shepherd, Thomas Williams, et al.
Nature Microbiology|December 22, 2020
Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into ScotlandAna da Silva Filipe, James G Shepherd, Thomas Williams, et al.
Nature Microbiology|January 19, 2021
Publisher Correction: Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into ScotlandAna da Silva Filipe, James G Shepherd, Thomas Williams, et al.
Lancet (London, England)|October 4, 2025
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trialJeremy Chataway, Thomas Williams, James Blackstone, et al.
BMJ Open|September 16, 2024
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UKJames Blackstone, Thomas Williams, Jennifer M Nicholas, et al.
Health Technology Assessment (Winchester, England)|June 29, 2026
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trialThomas Williams, James Blackstone, Nevin John, et al.
Influenza and Other Respiratory Viruses|February 24, 2023
Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019-2020Thomas Williams, Sandra Jackson, Ian Barr, et al.
Pageof 15

Showing results (141-150 of 148) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 148 results.
BMJ Neurology Open|September 12, 2024
Brain reserve and physical disability in secondary progressive multiple sclerosisNevin John, Yingtong Li, Floriana De Angelis, et al.
Nature Microbiology|January 28, 2021
Author Correction: Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into ScotlandAna da Silva Filipe, James G Shepherd, Thomas Williams, et al.
Nature Microbiology|December 22, 2020
Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into ScotlandAna da Silva Filipe, James G Shepherd, Thomas Williams, et al.
Nature Microbiology|January 19, 2021
Publisher Correction: Genomic epidemiology reveals multiple introductions of SARS-CoV-2 from mainland Europe into ScotlandAna da Silva Filipe, James G Shepherd, Thomas Williams, et al.
Lancet (London, England)|October 4, 2025
Effect of repurposed simvastatin on disability progression in secondary progressive multiple sclerosis (MS-STAT2): a phase 3, randomised, double-blind, placebo-controlled trialJeremy Chataway, Thomas Williams, James Blackstone, et al.
BMJ Open|September 16, 2024
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis (MS-STAT2): protocol for a multicentre, randomised controlled, double-blind, phase 3 clinical trial in the UKJames Blackstone, Thomas Williams, Jennifer M Nicholas, et al.
Health Technology Assessment (Winchester, England)|June 29, 2026
Evaluating the effectiveness of simvastatin in slowing the progression of disability in secondary progressive multiple sclerosis: a synopsis of MS-STAT2, a multicentre, randomised controlled, double-blind, phase 3 clinical trialThomas Williams, James Blackstone, Nevin John, et al.
Influenza and Other Respiratory Viruses|February 24, 2023
Results from the second WHO external quality assessment for the molecular detection of respiratory syncytial virus, 2019-2020Thomas Williams, Sandra Jackson, Ian Barr, et al.
Pageof 15